[HTML][HTML] SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection

Q Wang, ZH Gümüş, C Colarossi, L Memeo… - Journal of Thoracic …, 2023 - Elsevier
We review research regarding the epidemiology, risk factors, genetic susceptibility,
molecular pathology, and early detection of SCLC, a deadly tumor that accounts for 14% of …

Mechanisms contributing to the comorbidity of COPD and lung cancer

A Forder, R Zhuang, VGP Souza, LJ Brockley… - International Journal of …, 2023 - mdpi.com
Lung cancer and chronic obstructive pulmonary disease (COPD) often co-occur, and
individuals with COPD are at a higher risk of developing lung cancer. While the underlying …

[HTML][HTML] Central and peripheral actions of nicotine that influence blood glucose homeostasis and the development of diabetes

Z Chen, X Liu, PJ Kenny - Pharmacological Research, 2023 - Elsevier
Cigarette smoking has long been recognized as a risk factor for type 2 diabetes (T2D),
although the precise causal mechanisms underlying this relationship remain poorly …

Multifactorial diseases of the heart, kidneys, lungs, and liver and incident cancer: epidemiology and shared mechanisms

C Shi, S de Wit, E Učambarlić… - Cancers, 2023 - mdpi.com
Simple Summary Multifactorial diseases are caused by a combination of genetic and
environmental factors and various risk factors that accumulate with age. Cardiovascular …

[HTML][HTML] Nicotinic acetylcholine receptor subtype expression, function, and pharmacology: therapeutic potential of α-conotoxins

HS Tae, DJ Adams - Pharmacological Research, 2023 - Elsevier
The pentameric nicotinic acetylcholine receptors (nAChRs) are typically classed as muscle-
or neuronal-type, however, the latter has also been reported in non-neuronal cells. Given …

Contribution of the α5 nAChR subunit and α5SNP to nicotine-induced proliferation and migration of human cancer cells

I Papapostolou, D Ross-Kaschitza, F Bochen, C Peinelt… - Cells, 2023 - mdpi.com
Nicotine in tobacco is known to induce tumor-promoting effects and cause chemotherapy
resistance through the activation of nicotinic acetylcholine receptors (nAChRs). Many …

Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

J Shi, K Shiraishi, J Choi, K Matsuo, TY Chen… - Nature …, 2023 - nature.com
Lung adenocarcinoma is the most common type of lung cancer. Known risk variants explain
only a small fraction of lung adenocarcinoma heritability. Here, we conducted a two-stage …

Global burden of cancers attributable to tobacco smoking, 1990–2019: an ecological study

R Sharma, B Rakshit - EPMA Journal, 2023 - Springer
Aim and background Identifying risk factors for cancer initiation and progression is the
cornerstone of the preventive approach to cancer management and control (EPMA J. 4 (1) …

Survivin-targeted nanomedicine for increased potency of abiraterone and enzalutamide against prostate cancer

A Baker, A Syed, M Mohany, AM Elgorban… - European Journal of …, 2023 - Elsevier
Prostate cancer is the leading and most aggressive cancer around the world, several
therapeutic approaches have emerged but none have achieved the satisfactory result …

[HTML][HTML] Genomic medicine to reduce tobacco and related disorders: translation to precision prevention and treatment

LS Chen, TB Baker, A Ramsey, CI Amos… - Addiction neuroscience, 2023 - Elsevier
Genomic medicine can enhance prevention and treatment. First, we propose that advances
in genomics have the potential to enhance assessment of disease risk, improve prognostic …